Azacytidine In Myelodysplastic Syndromes Phase Iii Trial
Research Grant
Administered By
Duke Cancer Institute
Awarded By
Food and Drug Administration
Start Date
April 1, 1995
End Date
March 31, 1997
Administered By
Duke Cancer Institute
Awarded By
Food and Drug Administration
Start Date
April 1, 1995
End Date
March 31, 1997